Cognex (CGNX) Cash & Equivalents (2009 - 2026)

Cognex (CGNX) has reported Cash & Equivalents for 18 consecutive years, with $237.3 million the latest figure, recorded in Q2 2026.

• Cash & Equivalents for Q2 2026 came in at $237.3 million, up 65.12% year-over-year; the trailing twelve-month figure through Apr 2026 was $237.3 million (up 65.12% YoY), and the FY2025 annual result was $262.9 million, up 41.29% from the prior year.
• Cash & Equivalents was $237.3 million for Q2 2026 at Cognex, down from $262.9 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $395.5 million in Q4 2023 and troughed at $7.0 million in Q2 2022.
• Average Cash & Equivalents over 5 years is $196.4 million, with a median of $181.4 million recorded in 2022.
• Year-over-year, Cash & Equivalents slumped 97.12% in 2022 and soared 2244.97% in 2023.
• Over 5 years, Cash & Equivalents stood at $181.4 million in 2022, then advanced by 11.73% to $202.7 million in 2023, then declined by 8.17% to $186.1 million in 2024, then surged by 41.29% to $262.9 million in 2025, then decreased by 9.73% to $237.3 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $237.3 million in Q2 2026, $262.9 million in Q4 2025, and $245.9 million in Q3 2025.